Mood disorder

Jonathan Covey MD, JD is recognized by Continental Who's Who

Retrieved on:

Friday, January 22, 2021

Psychiatry, Psychiatric diagnosis, Abnormal psychology, Articles, Psychology, Mood disorder, Attention deficit hyperactivity disorder, Post-traumatic stress disorder

COLORADO SPRINGS, Colo., Jan. 22, 2021 /PRNewswire/ --Jonathan Covey MD, JD, is being recognized by Continental Who's Who as a Top Psychiatrist for his professional excellence in the field of Psychiatry and his outstanding leadership within his practice.

Key Points:

COLORADO SPRINGS, Colo., Jan. 22, 2021 /PRNewswire/ --Jonathan Covey MD, JD, is being recognized by Continental Who's Who as a Top Psychiatrist for his professional excellence in the field of Psychiatry and his outstanding leadership within his practice.
Covey is currently offering telemedicine services in the state of Colorado.
He offers a vast repertoire of valuable knowledge and experience in mood disorders, anxiety, bipolar, ADHD, depression, anxiety, PTSD, and more.
Dr.

Short Days Have You Feeling Down? These Three Supplements Help Combat Seasonal Affective Disorder

Retrieved on:

Monday, December 14, 2020

Branches of biology, Circadian rhythm, Health, Seasonal affective disorder, Orthomolecular medicine, Melatonin, Mood disorder, Vitamin D deficiency, Vitamin D, Delayed sleep phase disorder

This disruption of the natural rhythm, along with the loss of natural light exposure can lead to something called Seasonal Affective Disorder (SAD).

Key Points:

This disruption of the natural rhythm, along with the loss of natural light exposure can lead to something called Seasonal Affective Disorder (SAD).
Though SAD is typically associated with a Vitamin D deficiency, symptoms can actually be triggered by an irregular sleep schedule.
This can significantly impact the sleep/wake cycles mediated by the balance between the neurohormone melatonin and cortisol in our bodies.
Luckily, leading supplement brand Advanced Orthomolecular Research (AOR) can assist in offering a personalized nutrition approach to tackling SAD.

Tackling Teenage Depression: Albert Einstein College of Medicine and Montefiore Health System Receive $4 Million NIH Grant to Support Search for Biomarkers for Severe Depression

Retrieved on:

Tuesday, November 10, 2020

Montefiore Health System, Psychiatric diagnosis, Abnormal psychology, The Bronx, Montefiore, Albert Einstein College of Medicine, Major depressive disorder, Mood disorder, Healthcare in New York City, New York City, Yeshiva University, Montefiore Medical Center

While many recover from such an episode, a significant portion will develop severe depression or a chronic mood disorder.

Key Points:

While many recover from such an episode, a significant portion will develop severe depression or a chronic mood disorder.
We are trying to predict which teens are likely to develop severe and/or sustained depression so that we stave off devastating outcomes."
Dr. Gabbay is also a clinical psychiatrist at Montefiore and co-director of the Psychiatry Research Institute at Montefiore Einstein (PRIME).
About Albert Einstein College of Medicine Albert Einstein College of Medicine is one of the nation's premier centers for research, medical education and clinical investigation.

Juvenile Bipolar Research Foundation is thrilled to announce The Fear of Harm Parent Training Course: Our innovative new online educational tools for parents

Retrieved on:

Wednesday, June 24, 2020

Psychiatry, Abnormal psychology, Psychiatric diagnosis, Psychology, Behavioural sciences, Emotions, Mood disorder, Fear, RTT

WHITE PLAINS, N.Y., June 24, 2020 /PRNewswire-PRWeb/ -- Juvenile Bipolar Research Foundation is thrilled to announce the launch of our innovative new online educational tools for parents.

Key Points:

WHITE PLAINS, N.Y., June 24, 2020 /PRNewswire-PRWeb/ -- Juvenile Bipolar Research Foundation is thrilled to announce the launch of our innovative new online educational tools for parents.
The Fear of Harm Parent Training Course explains in clear and uncomplicated language how to recognize its symptoms, advocate for accurate diagnosis, and manage symptoms at home.
JBRF has the only program offering research based information on the causes of and treatments for this new disorder: Thermoregulatory Fear of Harm Mood Disorder.
The Fear of Harm Parent Training Course consists of 5 modules, each containing a series of lessons, that go step-by-step through how to recognize and treat Fear of Harm, how to manage symptoms, manage discipline, and understand the effects of Fear of Harm.

Sage Therapeutics Announces the New England Journal of Medicine Publishes Data from Phase 2 Trial with SAGE-217 in Major Depressive Disorder

Retrieved on:

Wednesday, September 4, 2019

Mental health, Health, Clinical trials, Pharmaceutical, Biotechnology, RTT, Psychiatric diagnosis, Psychiatry, Depression, Chemical compounds, Antidepressants, Organic compounds, Abnormal psychology, Zuranolone, Major depressive disorder, Postpartum depression, Mood disorder

Results published in NEJM also include additional data from multiple secondary endpoints, all of which generally favored SAGE-217 at the end of treatment (Day 15).

Key Points:

Results published in NEJM also include additional data from multiple secondary endpoints, all of which generally favored SAGE-217 at the end of treatment (Day 15).
In the study, SAGE-217 was generally well tolerated with a safety profile consistent with that seen in earlier SAGE-217 trials.
Overall reports of treatment emergent adverse events (TEAEs) were 53.3% in the SAGE-217 group and 45.5% in the placebo group.
SAGE-217 is currently being developed for major depressive disorder, postpartum depression, and certain other mood disorders.

Depression and Bipolar Support Alliance Selects PlatformQ Health to Lead New Digital Educational Initiative to Address the Mental Health Crisis

Retrieved on:

Thursday, August 22, 2019

Bipolar disorder, Human behavior, Abnormal psychology, Articles, Psychiatry, Support groups, Depression and Bipolar Support Alliance, Psychiatric diagnosis, Mood disorder, Mental health, Depression, DBSA

"We are thrilled to expand our partnership with PlatformQ Health to create more action-oriented mental health education," shared Phyllis Foxworth, DBSA Advocacy Vice President.

Key Points:

"We are thrilled to expand our partnership with PlatformQ Health to create more action-oriented mental health education," shared Phyllis Foxworth, DBSA Advocacy Vice President.
Over 21 million people in the U.S. live with mood disorders, and these conditions are associated with significant costs.
The Depression and Bipolar Support Alliance (DBSA) is a leading peer-focused mental health organization whose mission is "to improve the lives of people living with mood disorders."
To improve patient care, PlatformQ Health creates video-first educational modules with premier partners, so learners can better understand conditions, available treatment options, and the latest research.

Survey: Misconceptions Regarding Postpartum Depression Persist Despite Increased Exposure and Discussion

Retrieved on:

Monday, January 7, 2019

A survey on postpartum depression was evenly distributed across the country to more than 200 women.

Key Points:

A survey on postpartum depression was evenly distributed across the country to more than 200 women.
Respondents anonymously answered questions regarding the effects of postpartum depression on women, their babies, and family.
Kelsey-Seybold Clinic physicians reviewed the results and found that misconceptions regarding postpartum depression persist, despite increased exposure and discussion in recent years.
Postpartum depression is a serious mood disorder, which may affect the mothers ability to care for herself and her newborn, said Deepali Patni, M.D., F.A.C.O.G.